Glyn Stacey's Biography

• Home
• |
• Registration
• |
• Submissions
  • Submission Guidelines
• |
• Agenda
  • Keynote Speakers
  • Agenda Day 1
  • Agenda Day 2
• |
• Exhibition
• |
• Venue
• |
• Media
• |
• Short Courses
  • Workshops
• |
• Co-Located Conferences
• |
• Posters
  • Submission Guidelines
• |
• Social Program
• |

QC and Assay Development for Product Safety Testing Using Pluripotent Stem Cell Based Systems

Monday, 6 March 2017 at 10:15

Add to Calendar ▼2017-03-06 10:15:002017-03-06 11:15:00Europe/LondonQC and Assay Development for Product Safety Testing Using Pluripotent Stem Cell Based SystemsSELECTBIOenquiries@selectbiosciences.com

The development of assays for product safety testing based on human pluripotent stem cell lines requires careful evaluation of the starting cell line and qualification of the protocol to deliver the final cells for testing. In the is presentation will consider experiences in addressing these issues in the Seurat-1 EC/Colipa funded programme and new initiatives in the development of best practice for stem cell culture and assay development.